Merck & Co Puts A Date On Spinning Off Biosimilars

Plans Have Been Public For 12 Months

 
• By Dean Rudge
  
Spinning top
The Merck spin-off Organon will take residence in New Jersey. • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products